Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical study shows Cynata's MSCs are effective in model of diabetic ulcers

June 5, 2018

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Primary efficacy endpoint not achieved in phase II study of teslexivir gel in condyloma

June 5, 2018

Yakult licenses rights to duvelisib in Japan

June 5, 2018

Perjeta approved in E.U. for adjuvant treatment of HER2-positive early breast cancer

June 5, 2018

Mabion submits MAA for rituximab biosimilar Mabion-CD20

June 5, 2018

Isomer discovery could yield countless new drugs

June 5, 2018

Clovis seeks to expand use of Rubraca in E.U. in recurrent ovarian cancer

June 5, 2018

FDA clears Nant to begin clinical trials with neoepitope yeast vaccine YE-NEO-011

June 5, 2018

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.